The Pathogenesis and Treatment of Diffuse Midline Glioma

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 May 2026 | Viewed by 30

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurosurgery, Advocate Aurora Healthcare, Chicago, IL 60657, USA
Interests: pediatric brain tumors; diffuse midline glioma; high-grade glioma; H3K27M mutant glioma; liquid biopsy

Special Issue Information

Dear Colleagues,

Pediatric brain tumors are the most common solid tumor in children, and diffuse midline gliomas (DMGs) persist as the most morbid despite decades of research and clinical trials aiming to improve clinical outcomes. However, increasingly safe access to tumor tissue for study has led to the elucidation of the genomic landscape contributing to tumorigenesis, including the prevalence of the H3K27M mutation, and has provided an opportunity to better understand DMG biology and identify novel, targeted, and more effective therapies. Coupled with advances in surgical tissue acquisition, advancing sequencing techniques and data sharing platforms have led to a significant increase in scientific studies and clinical trials for DMGs in the last decade, meeting a critical unmet need for better treatment for these patients.

Given these recent developments in studies investigating DMG biology, diagnosis, clinical monitoring and molecularly targeted treatment, we aim to gather contemporary reports from experts in the field to curate a Special Issue of Cancers focused on this topic to advance the understanding of tumor biology and treatment for this disease. This Special Issue is intended to highlight recent studies on the biology and clinical features of diffuse midline glioma, as well as novel findings related to mechanisms of tumorigenesis, the effects of and resistance to targeted therapy, as well as the development of biomarker detection and liquid biopsy techniques for diagnosis and disease monitoring. We also highlight the role of patient advocacy and philanthropic organizations, who have significantly advanced attention to and research into this diagnosis with their support. Here, we present original research and review articles addressing our current understanding of the clinical course and biology of diffuse midline glioma, and together aim to identify future directions for improved clinical outcomes for these patients.

Dr. Amanda Muhs Saratsis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatric brain tumors
  • diffuse midline glioma
  • high-grade glioma
  • H3K27M mutant glioma
  • liquid biopsy
  • diffuse intrinsic pontine glioma

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop